DAFNA Capital Management »

Q32 Bio shares owned by DAFNA Capital Management

Quarter-by-quarter ownership of Q32 Bio (QTTB) shares owned by DAFNA Capital Management from 13F filings

Historical chart of DAFNA Capital Management investment in Q32 Bio

Tip: Access up to 7 years of quarterly data

All positions including Q32 Bio held by DAFNA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Q32 Bio by DAFNA Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $419k 33k 12.74

More positions owned by DAFNA Capital Management

Revolution Medicines (RVMD)
Spdr S&p Biotech Etf Etf (XBI)
Compass Pathways Sponsored Ads (CMPS)
Stereotaxis Com New (STXS)
Nektar Therapeutics Com New (NKTR)
Denali Therapeutics (DNLI)
Ideaya Biosciences (IDYA)
AtriCure (ATRC)
Xenon Pharmaceuticals (XENE)
Cytokinetics Com New (CYTK)
Arcus Biosciences Incorporated (RCUS)
Ascendis Pharma A/s Ord Shs (ASND)
Neurocrine Biosciences (NBIX)
Axogen (AXGN)
Insulet Corporation (PODD)

View all positions for DAFNA Capital Management

Top funds holding Q32 Bio

OrbiMed Advisors
Boxer Capital Management
Atlas Venture Life Science Advisors
BVF
RA Capital Management
Point72 Asset Management
Opaleye Management
Logos Global Management
SummitTX Capital
Ikarian Capital
Vanguard Capital Management
Woodline Partners
American Century Companies
Sanofi
Acadian Asset Management

View all funds holding Q32 Bio